| MeSH term | MeSH ID | Detail |
|---|---|---|
| Candidiasis, Vulvovaginal | D002181 | 8 associated lipids |
| Angina Pectoris | D000787 | 27 associated lipids |
| Edema | D004487 | 152 associated lipids |
Total
3
Tribehenin
Tribehenin is a lipid of Glycerolipids (GL) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 850 references associated with Tribehenin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Tribehenin
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Tribehenin
NCBI Entrez Crosslinks
All references with Tribehenin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| McGinity M et al. | Implant compositions for the unidirectional delivery of drugs to the brain. | 2017 | Drug Dev Ind Pharm | pmid:28422529 |
| Hariharan M et al. | Effect of formulation composition on the properties of controlled release tablets prepared by roller compaction. | 2004 | Drug Dev Ind Pharm | pmid:15285329 |
| Shah M et al. | Oral solid compritol 888 ATO nanosuspension of simvastatin: optimization and biodistribution studies. | 2011 | Drug Dev Ind Pharm | pmid:21128704 |
| UÄŸurlu T et al. | Effects of lubricants on binary direct compression mixtures. | 2010 | Drug Discov Ther | pmid:22491169 |
| Thakkar H et al. | Enhanced retention of celecoxib-loaded solid lipid nanoparticles after intra-articular administration. | 2007 | Drugs R D | pmid:17767393 |
| Rahman Z et al. | Non-destructive methods of characterization of risperidone solid lipid nanoparticles. | 2010 | Eur J Pharm Biopharm | pmid:20470882 |
| Sznitowska M et al. | The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN). | 2017 | Eur J Pharm Biopharm | pmid:27815177 |
| Khan S et al. | Tacrolimus-loaded nanostructured lipid carriers for oral delivery - Optimization of production and characterization. | 2016 | Eur J Pharm Biopharm | pmid:27449630 |
| Ravi PR et al. | Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism. | 2014 | Eur J Pharm Biopharm | pmid:24378615 |
| Dudhipala N and Veerabrahma K | Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation. | 2017 | Eur J Pharm Biopharm | pmid:27810472 |